FAST ASSIGNMENT OF ADEQUATE NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER PATIENTS BASED ON THE IDENTIFICATION OF CONSTITUTIONAL BRCA1 MUTATIONS
摘要
Disclosed is a method and composition for optimizing the efficiency of breast cancer neoadjuvant chemotherapy, depending on the particular constitutional genotype characteristics of the gene BRCA1 in each patient. Generally, the invention concerns a new method to improve neoadjuvant therapy depending on a particular constitutional genotype. Subject of invention allow to synthesize DNA and identification of germline BRCA1 genetic abnormalities which are correlated with a significantly decreased clinical response to neoadjuvant chemotherapy based on taxane-derived cytostatics in breast cancer patients.
申请公布号
EP2032720(B1)
申请公布日期
2014.05.21
申请号
EP20070747744
申请日期
2007.06.01
申请人
POMORSKI UNIWERSYTET MEDYCZNY;BYRSKI, TOMASZ;GRONWALD, JACEK;LUBINSKI, JAN;HUZARSKI, TOMASZ;NAROD, STEVEN
发明人
BYRSKI, TOMASZ;GRONWALD, JACEK;LUBINSKI, JAN;HUZARSKI, TOMASZ;NAROD, STEVEN